These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 17527071)
1. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators. An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071 [TBL] [Abstract][Full Text] [Related]
2. Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer. Shia J; Black D; Hummer AJ; Boyd J; Soslow RA Hum Pathol; 2008 Jan; 39(1):116-25. PubMed ID: 17949789 [TBL] [Abstract][Full Text] [Related]
3. Frameshift mutations in the bax gene are not involved in development of ovarian endometrioid carcinoma. Cao SN; Chang KH; Luthra R; Liu J Mod Pathol; 2003 Oct; 16(10):1048-52. PubMed ID: 14559989 [TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling. Risinger JI; Maxwell GL; Chandramouli GV; Aprelikova O; Litzi T; Umar A; Berchuck A; Barrett JC Cancer Res; 2005 Jun; 65(12):5031-7. PubMed ID: 15958545 [TBL] [Abstract][Full Text] [Related]
5. Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma. Modica I; Soslow RA; Black D; Tornos C; Kauff N; Shia J Am J Surg Pathol; 2007 May; 31(5):744-51. PubMed ID: 17460459 [TBL] [Abstract][Full Text] [Related]
7. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression. Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947 [TBL] [Abstract][Full Text] [Related]
8. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma? Alvarez T; Miller E; Duska L; Oliva E Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825 [TBL] [Abstract][Full Text] [Related]
9. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium. Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909 [TBL] [Abstract][Full Text] [Related]
10. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment. Peiró G; Peiró FM; Ortiz-Martínez F; Planelles M; Sánchez-Tejada L; Alenda C; Ceballos S; Sánchez-Payá J; Laforga JB Hum Pathol; 2013 Feb; 44(2):218-25. PubMed ID: 22955108 [TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor isoforms as a prognostic marker in human endometrial carcinoma. Saito S; Ito K; Nagase S; Suzuki T; Akahira J; Okamura K; Yaegashi N; Sasano H Cancer Sci; 2006 Dec; 97(12):1308-14. PubMed ID: 16999816 [TBL] [Abstract][Full Text] [Related]
13. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232 [TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Caduff RF; Johnston CM; Svoboda-Newman SM; Poy EL; Merajver SD; Frank TS Am J Pathol; 1996 May; 148(5):1671-8. PubMed ID: 8623934 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences. Soslow RA; Bissonnette JP; Wilton A; Ferguson SE; Alektiar KM; Duska LR; Oliva E Am J Surg Pathol; 2007 Jul; 31(7):979-87. PubMed ID: 17592263 [TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability did not predict individual survival in sporadic stage II and III rectal cancer patients. Meng WJ; Sun XF; Tian C; Wang L; Yu YY; Zhou B; Gu J; Xia QJ; Li Y; Wang R; Zheng XL; Zhou ZG Oncology; 2007; 72(1-2):82-8. PubMed ID: 18004081 [TBL] [Abstract][Full Text] [Related]
17. Synchronous endometrial and ovarian carcinomas: analysis of genetic relationship of the tumors. Nishimura N; Hachisuga T; Nabeshima K; Kawarabayashi T Int J Oncol; 2005 Dec; 27(6):1519-26. PubMed ID: 16273207 [TBL] [Abstract][Full Text] [Related]
19. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400 [TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger. Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]